Italian descent, mostly from Sardinia. We confirmed a tight linkage [6=0.00, Z(O) =4-07] between the WND and ESD loci, and provided suggestive evidence for linkage [0=0-00, Z(O)=1.85] of the WND locus with D13SJO. Multipoint linkage analysis indicated the following order: centromere-Dl3SJ-Dl3SJO-WND-ESD-D13S2. RFLP analysis at these two loci in our families allowed us either to define the carrier status (50%) or to exclude the homozygous state (25%) in the great majority of unaffected sibs.
Wilson's disease, or hepatolenticular degeneration, is a rare, autosomal recessive disorder characterised by impaired biliary excretion and defective incorporation of copper into ceruloplasmin. This results in hepatic and extra-hepatic copper accumulation, low plasma concentration, and increased urinary excretion.1 Clinical presentation occurs in the first or second decade of life and is characterised either by liver disease or extrapyramidal syndrome. The variability of the clinical picture and age at presentation suggests genetic heterogeneity.2 The molecular basis of the disease is not known. Chelation therapy with penicillamine is highly effective, especially when initiated before irreversible organ damage has occurred.
Preclinical diagnosis, based on low ceruloplasmin younger and seven older than 14 years. In the group of young patients, 16 had chronic liver disease and three were asymptomatic. In the group of older patients, two had the extrapyramidal syndrome, two had chronic liver disease, and three were asymptomatic.
Diagnosis was based on reduced serum ceruloplasmin and copper levels, high urinary copper excretion, and copper accumulation in the liver, evaluated by biopsy. The pertinent laboratory data on the 26 patients evaluated are presented in table 1.
Serum ceruloplasmin levels, investigated in 34 parents, were normal in 31 and reduced in three.
DNA ANALYSIS
Leucocyte DNA extraction and restriction endonuclease analysis were carried out as previously described.8 Three anonymous probes, p7F12, p7D2, and p9D11, which detect RFLPs at the chromosome 13 loci D13SI, D13SJO, and D13S2 respectively, were used to hybridise Southern blots of DNA samples from members of the Wilson's disease families. In addition, an ESD cDNA probe was used to detect RFLPs at the ESD locus. The ESD isoenzymes were also determined according to Hopkinson et al.9 LINKAGE ANALYSIS Pairwise linkage analysis between the WND locus and each of the chromosome 13 polymorphic loci in 17 informative families was performed by the lod scores method, using the MLINK program from the linkage package,10 assuming a recessive model with complete penetrance and a population frequency of the WND gene of 0-002.7 Genotypes from different polymorphisms detected by single copy probes were combined into chromosomal haplotypes. Separate lod scores for sex and one lod unit confidence intervals for the estimated recombination fractions were calculated as recommended at HGM8.11
Multipoint linkage analysis to determine the most likely order of the four marker loci and the relative position of the Wilson's disease locus among the marker loci was performed using the ILINK and LINKMAP programs from the LINKAGE package. Wilson's disease families were studied at the four polymorphic loci. Because of the high recombination between DJ3SI and D13S2 and the WND locus (0=0.049 and 0-09 respectively, table 3) only ESD and D13SJO, which showed the lowest recombination fraction with WND in our study, were used for carrier detection.
The RFLPs at these polymorphic loci were combined to obtain a chromosomal haplotype. Haplotype analysis may avoid misdiagnosis resulting from recombination between WND and one of the other two loci, an example of which is illustrated in fig 2. The linkage phase was established in both parents in three families (completely informative families), in one parent only in 11 (partially informative families), and in neither in three (uninformative families) (table 4) .
In eight families with multiple cases, the affected sibs shared identical chromosome 13 haplotypes which were never detected in unaffected sibs. Although in our samples the maximum likelihood estimate of the recombination distance between WND and the two linked RFLP markers is 0-00, the 90% confidence interval for the recombination distance should be used for the conservative estimate of the probability of an at risk fetus being affected with Wilson's disease. On the assumption that ESD and D13SJ0 flank WND, by using both polymorphic loci considered as haplotypes in informative families, the risk of a sib sharing the same haplotypes as the proband would be adjusted from 25% to 98-2%, while the probability of being heterozygous would be 1-7%. If the order of loci is D13S1O-ESD-WND, false negative and false positive diagnoses would be in the order of 11-3% and 5.8% respectively. Prenatal diagnosis of Wilson's disease will be greatly facilitated when new probes linked to the WND locus are available and the order of the probes along chromosome 13 defined.
